Ajanta Pharma
Ajanta Pharma Limited, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of a diverse range of formulations. Founded in 1973, the company has established a strong presence in various operational regions, including Asia, Africa, and the Middle East. Ajanta Pharma is renowned for its focus on therapeutic areas such as ophthalmology, dermatology, and pain management, offering unique products that cater to specific medical needs. With a commitment to quality and innovation, the company has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. Recognised for its robust market position, Ajanta Pharma continues to expand its global footprint, driven by a dedication to enhancing patient care through effective and affordable healthcare solutions.
DitchCarbon Score
How does Ajanta Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ajanta Pharma's score of 19 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ajanta Pharma's reported carbon emissions
In 2023, Ajanta Pharma reported total carbon emissions of approximately 56,134,900 kg CO2e, comprising about 4,368,550 kg CO2e from Scope 1 and about 51,847,350 kg CO2e from Scope 2 emissions. This represents a slight decrease in Scope 1 emissions compared to 2022, where they were approximately 4,611,220 kg CO2e, while Scope 2 emissions increased from about 46,633,150 kg CO2e in the previous year. For 2022, the total emissions were approximately 51,944,470 kg CO2e, with Scope 1 emissions at about 4,611,220 kg CO2e and Scope 2 emissions at approximately 46,633,150 kg CO2e. In 2021, the company reported total emissions of about 45,223,660 kg CO2e, with Scope 1 emissions of approximately 3,660,360 kg CO2e and Scope 2 emissions of about 41,756,300 kg CO2e. Despite these figures, Ajanta Pharma has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to monitor its emissions and aims to improve its carbon footprint in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 3,660,360 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 41,756,300 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ajanta Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
